Search

everythinglearnresearchcommunity

for

Search:↓

Women with androgenetic alopecia have lower SHBG levels.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

Higher SHBG levels are linked to less severe hair loss in women, but vitamin D levels don't seem to affect hair loss.

Cyclosporin A does not change sex hormone levels.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Genetic response to androgens is key in female pattern baldness, not SHBG levels.

Women with more 3α,17β-androstanediol glucuronide compared to sex hormone binding globulin are more likely to have female pattern baldness.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

Hirsutism severity is linked to androgen levels, especially in women with a lower LH/FSH ratio.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Women with androgenetic alopecia have normal levels of most blood steroids and binding proteins, but higher dehydroepiandrosterone. Some also have low "sex hormone-binding globulin" and "corticosteroide-binding globulin" capacity, and high "free androgen index" and "free cortisol index". Diane treatment can normalize these levels and improve hair conditions.

Older men with low levels of a testosterone byproduct had a higher chance of developing an irregular heartbeat.

Women with hyperandrogenism have higher androgen levels and lower SHBG, which may contribute to conditions like excessive hair growth and early puberty.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

The combined Myo-inositol and D-chiro-inositol treatment improved weight, hormone levels, and skin conditions in women with PCOS.

Women with acromegaly often have irregular periods due to hormone imbalances and growth hormone effects.

Androgens like testosterone affect hair growth and oil production differently across body parts and individuals.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Hormonal imbalances are important in the development of male pattern baldness.

Choosing the right starting dose of Clomiphene Citrate for ovulation induction in PCOS women is challenging; higher BMI and hormone levels may indicate resistance to the standard dose.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

Acne severity is linked to higher levels of certain androgenic hormones, even when those levels are within the normal range.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.